Viewing Study NCT03290092


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2026-01-03 @ 8:18 PM
Study NCT ID: NCT03290092
Status: TERMINATED
Last Update Posted: 2019-11-12
First Post: 2017-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Taselisib in Overgrowth
Sponsor: Centre Hospitalier Universitaire Dijon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module